FDA Approves New HIV Treatments
The U.S. Food and Drug Administration (FDA) has approved pharmaceutical giant Merck’s Delstrigo and Pifeltro for the treatment of HIV-1 infection in adult patients...
Dual Regimens in Trials Show Promise
The Power of Two
Dual regimens show promise in clinical trials
by Chael Needle
At the International AIDS Conference in Amsterdam last July, ViiV Healthcare shared its...
An HIV Injectable Regimen Comes of Age
Without the Pill Box?
The First Long-Acting Injectable Regimen for Individuals Living with HIV Comes of Age
by Mel Baker
A funny thing happened on the way to...
ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment
ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment
Findings from the GEMINI and TANGO studies, reported at the 10th International AIDS Society...
LATEST POSTS
We Need to Bring Immune-Based HIV Therapies Off of the Sidelines
Dreaming of the Cells We Had
We Need to Bring Immune-Based Therapies Off of the Sidelines
by Jeannie Wraight
For most people living with HIV, antiretrovirals (ARVs)...
